Structual and Calcium Regulatory Proteins in Sarcopenia
肌肉减少症的结构蛋白和钙调节蛋白
基本信息
- 批准号:7667956
- 负责人:
- 金额:$ 26.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-06-01 至 2013-05-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAdenovirusesAgeAgingAmino AcidsAnimalsBiochemistryBiological AssayCalciumChemicalsElderlyFiberFunctional disorderGene TransferGoalsInvestigationLinkLongevityModelingModificationMolecularMolecular BiologyMuscleMuscle ProteinsMyosin ATPaseMyosin Alkali Light ChainsMyosin Light ChainsPeptidesPerformancePhysiologicalPhysiologyPost-Translational Protein ProcessingPreparationProgress ReportsProtein IsoformsProteinsProteomicsPublicationsRattusRecombinantsResearchResearch DesignRoleSiteSkeletal MuscleSpeedStructureTechniquesTechnologyTestingTissuesTroponin CUpper armYouthage effectage groupage relatedagedgenetic regulatory proteinin vivoloss of functionmuscle agingnovelprematurepreventprotein expressionprotein functionprotein structureprotein structure functionpublic health relevancerepairedresearch studysarcopenia
项目摘要
DESCRIPTION (provided by applicant): Our long term goal is to determine the molecular mechanisms underlying the diminished skeletal muscle performance with age. We hypothesize that age-dependent damage of specific amino acid residues in key skeletal muscle proteins impacts skeletal muscle performance by altering protein structure and function. In support of this hypothesis, our previous investigations clearly demonstrate that the decline in specific force is due, in part, to changes in the structure of myosin resulting from site-specific post-translational modifications. However, changes in myosin do not explain the total age-related muscle dysfunction. Our previous findings indicate an age-induced alteration in calcium sensitivity, strongly implicating Troponin C. There is a significant reduction in shortening velocity in type II fibers that cannot be explained by myosin isoform switching, suggesting that the regulatory proteins, myosin light chains, are involved. This proposal has two aims: AIM 1. Determine the role of Troponin C in age-related skeletal muscle dysfunction (reduction in calcium sensitivity). We predict that specific amino acids are modified in Troponin C with age, rendering the protein less sensitive to calcium. AIM 2. Determine the role of myosin light chains (MLC1f and MLC3f) in age-related skeletal muscle dysfunction (reduction in contraction velocity). In order to test mechanistically how these two proteins contribute to muscle dysfunction we will use three approaches. First, we will purify Troponin C and myosin light chains from different aged rats and test their physiological interactions. Second we will identify the in vivo type of post-translational chemical modification and the specific amino acid site of modification using proteomic technology. Third, we will use Recombinant Adenovirus technology to over-express specific myosin light chain isoforms in different aged rats to test mechanistically how alterations in protein expression contribute directly to the slowing of contraction. The Fischer 344 rat will be our aging model concentrating on three age groups (adult, old and aged) representing the lifespan of the animal. This proposed research brings together a powerful research team and a combination of techniques, including physiology, biochemistry, proteomics, and molecular biology to test fundamental questions regarding novel roles for Troponin C and myosin light chains in aging. Once we are armed with the type of chemical modification and the specific site of modification, we will be able to test if these in vivo modifications are responsible for altered protein structure/function with age. PUBLIC HEALTH RELEVANCE: During aging there are many opportunities for appropriately transcribed peptides and proteins to become structurally altered. Previous studies show that accumulation of altered proteins, due to post-translational modifications, is correlated with a loss of function. Therefore, it is critical to identify the alterations of specific proteins during aging and to define their roles in age-related muscle dysfunction. Presently, the role of age- related post-translational modifications of specific protein amino acids on protein structure and protein function in key skeletal muscle proteins is unknown. This proposal investigates two key skeletal muscle proteins, Troponin C and myosin light chains, which are candidates to explain age-related muscle dysfunction.
描述(由申请人提供):我们的长期目标是确定骨骼肌性能随年龄下降的分子机制。我们推测,骨骼肌关键蛋白质中特定氨基酸残基的年龄依赖性损伤通过改变蛋白质结构和功能来影响骨骼肌性能。为了支持这一假设,我们以前的研究清楚地表明,比力的下降是由于,在一定程度上,由位点特异性的翻译后修饰导致的肌球蛋白结构的变化。然而,肌球蛋白的变化不能解释总的年龄相关的肌肉功能障碍。我们以前的研究结果表明,年龄诱导的钙敏感性改变,强烈牵连肌钙蛋白C。有一个显着的缩短速度在II型纤维,不能解释肌球蛋白亚型转换,这表明,调节蛋白,肌球蛋白轻链,参与。该提案有两个目标:目标1。确定肌钙蛋白C在年龄相关性骨骼肌功能障碍(钙敏感性降低)中的作用。我们预测,随着年龄的增长,肌钙蛋白C中的特定氨基酸被修饰,使蛋白质对钙的敏感性降低。AIM 2.确定肌球蛋白轻链(MLC 1f和MLC 3f)在年龄相关性骨骼肌功能障碍(收缩速度降低)中的作用。为了从机制上测试这两种蛋白质如何导致肌肉功能障碍,我们将使用三种方法。首先,我们将从不同年龄的大鼠中纯化肌钙蛋白C和肌球蛋白轻链,并测试它们的生理相互作用。其次,我们将利用蛋白质组学技术鉴定体内翻译后化学修饰的类型和特定的氨基酸修饰位点。第三,我们将使用重组腺病毒技术在不同年龄的大鼠中过表达特定的肌球蛋白轻链亚型,以从机制上测试蛋白质表达的改变如何直接导致收缩减缓。Fischer 344大鼠将是我们的衰老模型,集中于代表动物寿命的三个年龄组(成年、老年和老年)。这项拟议的研究汇集了一个强大的研究团队和技术组合,包括生理学,生物化学,蛋白质组学和分子生物学,以测试有关肌钙蛋白C和肌球蛋白轻链在衰老中的新作用的基本问题。一旦我们掌握了化学修饰的类型和修饰的特定位点,我们将能够测试这些体内修饰是否是随着年龄改变蛋白质结构/功能的原因。公共卫生关系:在衰老过程中,有许多机会使适当转录的肽和蛋白质在结构上发生改变。先前的研究表明,由于翻译后修饰,改变的蛋白质的积累与功能丧失相关。因此,确定衰老过程中特定蛋白质的变化并确定其在与年龄相关的肌肉功能障碍中的作用至关重要。目前,在关键骨骼肌蛋白中,特定蛋白质氨基酸的年龄相关翻译后修饰对蛋白质结构和蛋白质功能的作用是未知的。该提案研究了两种关键的骨骼肌蛋白,肌钙蛋白C和肌球蛋白轻链,它们是解释年龄相关肌肉功能障碍的候选蛋白。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LaDora V Thompson其他文献
LaDora V Thompson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LaDora V Thompson', 18)}}的其他基金
Academic Leadership Award - The Translational Rehabilitation in Geroscience Initiative
学术领导奖 - 老年科学转化康复倡议
- 批准号:
10201136 - 财政年份:2021
- 资助金额:
$ 26.76万 - 项目类别:
Academic Leadership Award - The Translational Rehabilitation in Geroscience Initiative
学术领导奖 - 老年科学转化康复倡议
- 批准号:
10592362 - 财政年份:2021
- 资助金额:
$ 26.76万 - 项目类别:
Academic Leadership Award - The Translational Rehabilitation in Geroscience Initiative
学术领导奖 - 老年科学转化康复倡议
- 批准号:
10380879 - 财政年份:2021
- 资助金额:
$ 26.76万 - 项目类别:
Structual and Calcium Regulatory Proteins in Sarcopenia
肌肉减少症的结构蛋白和钙调节蛋白
- 批准号:
7888620 - 财政年份:2009
- 资助金额:
$ 26.76万 - 项目类别:
Training Grant: Functional Proteomics of Aging
培训补助金:衰老的功能蛋白质组学
- 批准号:
8064758 - 财政年份:2008
- 资助金额:
$ 26.76万 - 项目类别:
Training Grant: Functional Proteomics of Aging
培训补助金:衰老的功能蛋白质组学
- 批准号:
7807134 - 财政年份:2008
- 资助金额:
$ 26.76万 - 项目类别:
Training Grant: Functional Proteomics of Aging
培训补助金:衰老的功能蛋白质组学
- 批准号:
7434885 - 财政年份:2008
- 资助金额:
$ 26.76万 - 项目类别:
Training Grant: Functional Proteomics of Aging
培训补助金:衰老的功能蛋白质组学
- 批准号:
8248739 - 财政年份:2008
- 资助金额:
$ 26.76万 - 项目类别:
Training Grant: Functional Proteomics of Aging
培训补助金:衰老的功能蛋白质组学
- 批准号:
7597010 - 财政年份:2008
- 资助金额:
$ 26.76万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 26.76万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 26.76万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 26.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 26.76万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 26.76万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 26.76万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 26.76万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 26.76万 - 项目类别:
Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 26.76万 - 项目类别:
Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 26.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)